Showing 11,041 - 11,060 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 1.16s Refine Results
  1. 11041

    Image_5_Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model.jpeg by Tahereh Soltantoyeh (15944541)

    Published 2024
    “…To overcome this challenge, researchers have investigated the potential of inhibiting specific immune checkpoint receptors, including A2aR (Adenosine A2 Receptor) and Tim3 (T cell immunoglobulin and mucin domain-containing protein 3), to enhance CAR T cell function. …”
  2. 11042

    Image_4_Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model.jpeg by Tahereh Soltantoyeh (15944541)

    Published 2024
    “…To overcome this challenge, researchers have investigated the potential of inhibiting specific immune checkpoint receptors, including A2aR (Adenosine A2 Receptor) and Tim3 (T cell immunoglobulin and mucin domain-containing protein 3), to enhance CAR T cell function. …”
  3. 11043

    Image_3_Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model.jpeg by Tahereh Soltantoyeh (15944541)

    Published 2024
    “…To overcome this challenge, researchers have investigated the potential of inhibiting specific immune checkpoint receptors, including A2aR (Adenosine A2 Receptor) and Tim3 (T cell immunoglobulin and mucin domain-containing protein 3), to enhance CAR T cell function. …”
  4. 11044

    Supplementary Material for: Prenatal Infection Decreases Calbindin, Decreases Purkinje Cell Volume and Density and Produces Long-Term Motor Deficits in Sprague-Dawley Rats by Wallace K. (4120819)

    Published 2010
    “…Pups in the <i>E. coli</i> group also had a decrease in the number of Purkinje cells, as well as a decrease in Purkinje cell density and volume. …”
  5. 11045

    X‑ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson’s Disease Mouse Model by Jun Mou (4113313)

    Published 2024
    “…In a MPTP-induced Parkinson’s disease (PD) mouse model, <b>BI-43</b> manifested efficacy in mitigating locomotor deficits through reversing dopaminergic neuronal loss, reducing microglia, and decreasing levels of the sQC/gQC substrates, α-synuclein, and CCL2. …”
  6. 11046
  7. 11047
  8. 11048
  9. 11049

    A visual summary of the key study findings. by Joachim Worthington (8394213)

    Published 2024
    “…These changes would lead to an estimated increase of 255 colorectal cancer cases and 1,820 colorectal cancer deaths in Canada and 234 cases and 1,186 deaths in Australia over 2020–2030; a 1.9% and 2.4% increase in mortality, respectively, vs a scenario with no screening disruption or diagnostic/treatment delays. …”
  10. 11050
  11. 11051

    Cinnamaldehyde is a specific ligand for HL-IR. by Ceyan Kuang (8554557)

    Published 2025
    “…The ratio of bound/free 1-NPN gradually decreased as the concentration of 1-NPN increased, accompanied by a corresponding rise in fluorescence intensity. …”
  12. 11052
  13. 11053
  14. 11054

    A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications by Elewa, Hazem

    Published 2017
    “…The most critical pharmacogenetic consideration identified was the association of glucose-6-phosphate dehydrogenase deficiency with development of hemolytic anemia and decreased hemoglobin levels in patients treated with primaquine or a combination of chlorproguanil-dapsone-artesunate. …”
    Get full text
    Get full text
  15. 11055
  16. 11056
  17. 11057
  18. 11058

    A. Bar chart showing the percentage of participants experiencing chills in response to various stimuli, ordered by descending frequency. by Felix Alexandre Schoeller (20988295)

    Published 2025
    “…<p>B: Line graph indicating a decrease in the chills ratio over successive presentations of stimuli, with a marked drop between the fifth and sixth exposure. …”
  19. 11059
  20. 11060